Dashboard Tools Market News Investing Ideas Pricing About Us
Sign Up
Log in

Emyria Ltd
ASX:EMD

Watchlist Manager
Emyria Ltd Logo
Emyria Ltd
ASX:EMD
Watchlist
Price: 0.059 AUD 1.72% Market Closed
Market Cap: AU$47.4m
Write Note Create Alert Ask AI

Emyria Ltd
Investor Relations

Emyria Ltd. is a healthcare technology and services company. The firm provides care for its patients through its clinics gathering real-world-evidence (RWE) insights in relation to therapies, such as cannabinoid-based medicines and drug development. Its evidence-based drug development program (EMD-003) is focused on mental health and EMD-004 is focused on irritable bowel syndrome (IBS). The Company’s subsidiaries include Emyria Clinical Network Pty Ltd and Openly Care Inc.

Show more
Loading
EMD
S&P/ASX 300
1Y 3Y 5Y 10Y 15Y 20Y
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
No Earnings Calls Available

Management

Dr. Michael Winlo
MD & Director
No Bio Available
Dr. Alistair Vickery
Executive Medical Director & Director
No Bio Available
Mr. Joseph Daniel Ohayon ACA, MBA Intl Bus.
Chief Financial Officer
No Bio Available
Ms. Tracie Ernenwein
Head of Research & Drug Development
No Bio Available
Mary-Ann Rennie
Head of Corporate Operations
No Bio Available
Ms. Susan Patricia Park A.C.A., A.C.I.S., ACSA, AGIA, B.Com., C.A., F Fin,
Company Secretary
No Bio Available

Contacts

Address
PO Box 95,, North Perth
Contacts
+61300436363.0
www.emeraldclinics.com.au
sparklesyt

See Also

Summary
EMD intrinsic value, competitors valuation, and company profile.
DCF Valuation
EMD stock valuation using Discount Cash Flow valuation method.
Relative Valuation
EMD stock valuation using valuation multiples.
Wall Street Estimates
EMD price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
EMD stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Back to Top
ALPHA SPREAD
Follow us
Join more than 314,800+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.